14 Grants
2019
Cholesterol Toxicity as a Promising Target for Diabetes Prevention
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK114222-02), $393,543USD, 08/22/2018 -- 06/30/2020
2018
Cholesterol Toxicity as a Promising Target for Diabetes Prevention
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1R01DK114222-01A1), $388,254USD, 08/22/2018 -- 06/30/2020
2016
P&F Program
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK097512-02-7685), $227,178USD, 2016
2015
P&F Program
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1P30DK097512-01A1), $227,178USD, 2015
2012
Mechanisms of Membrane-Based Insulin Resistance &Therapeutic Reversal Strategies
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK082773-04), $328,285USD, 03/15/2009 -- 01/31/2014
2011
Mechanisms of Membrane-Based Insulin Resistance &Therapeutic Reversal Strategies
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK082773-03), $328,285USD, 03/15/2009 -- 01/31/2013
2010
Mechanisms of Membrane-Based Insulin Resistance &Therapeutic Reversal Strategies
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK082773-02), $365,904USD, 03/15/2009 -- 01/31/2013
 
Mechanisms of Membrane-Based Insulin Resistance &Therapeutic Reversal Strategies
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3R01DK082773-01S1), $40,000USD, 12/22/2009 -- 03/31/2010
2009
Mechanisms of Membrane-Based Insulin Resistance &Therapeutic Reversal Strategies
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1R01DK082773-01), $369,600USD, 03/15/2009 -- 01/31/2013
2008
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) (ID: 5R01AT001846-05), $270,764USD, 09/01/2004 -- 05/31/2010
2007
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) (ID: 5R01AT001846-04), $276,291USD, 09/01/2004 -- 05/31/2009
2006
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) (ID: 5R01AT001846-03), $276,291USD, 09/01/2004 -- 05/31/2009
2005
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) (ID: 5R01AT001846-02), $282,940USD, 09/01/2004 -- 05/31/2009
2004
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS
Elmendorf, Jeffrey S
National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) (ID: 1R01AT001846-01A1), $307,940USD, 09/01/2004 -- 05/31/2009